Cite
Kidney-accumulating olmesartan-loaded nanomicelles ameliorate the organ damage in a murine model of Alport syndrome.
MLA
Suh, Sang Heon, et al. “Kidney-Accumulating Olmesartan-Loaded Nanomicelles Ameliorate the Organ Damage in a Murine Model of Alport Syndrome.” International Journal of Pharmaceutics, vol. 600, May 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2021.120497.
APA
Suh, S. H., Mathew, A. P., Choi, H. S., Vasukutty, A., Kim, C. S., Kim, I. J., Ma, S. K., Kim, S. W., Park, I.-K., & Bae, E. H. (2021). Kidney-accumulating olmesartan-loaded nanomicelles ameliorate the organ damage in a murine model of Alport syndrome. International Journal of Pharmaceutics, 600, N.PAG. https://doi.org/10.1016/j.ijpharm.2021.120497
Chicago
Suh, Sang Heon, Ansuja Pulickal Mathew, Hong Sang Choi, Arathy Vasukutty, Chang Seong Kim, In Jin Kim, Seong Kwon Ma, Soo Wan Kim, In-Kyu Park, and Eun Hui Bae. 2021. “Kidney-Accumulating Olmesartan-Loaded Nanomicelles Ameliorate the Organ Damage in a Murine Model of Alport Syndrome.” International Journal of Pharmaceutics 600 (May): N.PAG. doi:10.1016/j.ijpharm.2021.120497.